text: Currently, the use of orally administered << MAO >> inhibitor antidepressants (eg, phenelzine, [[ tranylcypromine ]]) is limited by the risk of tyramine-provoked events (eg, acute hypertension and headache, also known as the "cheese reaction") when combined with dietary tyramine.